Chromocell Therapeutics Price Patterns
| CHRODelisted Stock | USD 16.50 1.25 8.20% |
Momentum 53
Impartial
Oversold | Overbought |
Using Chromocell Therapeutics hype-based prediction, you can estimate the value of Chromocell Therapeutics from the perspective of Chromocell Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Chromocell Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Chromocell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Chromocell Therapeutics after-hype prediction price | USD 16.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Chromocell |
Chromocell Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Chromocell Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Chromocell Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Chromocell Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Chromocell Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Chromocell Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Chromocell Therapeutics' historical news coverage. Chromocell Therapeutics' after-hype downside and upside margins for the prediction period are 16.50 and 16.50, respectively. We have considered Chromocell Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Chromocell Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Chromocell Therapeutics is based on 3 months time horizon.
Chromocell Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Chromocell Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chromocell Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Chromocell Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
16.50 | 16.50 | 0.00 |
|
Chromocell Therapeutics Hype Timeline
Chromocell Therapeutics is currently traded for 16.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Chromocell is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Chromocell Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 16.50. About 54.0% of the company shares are held by company insiders. The company recorded a loss per share of 12.0. Chromocell Therapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 2nd of July 2025. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty.Chromocell Therapeutics Related Hype Analysis
Having access to credible news sources related to Chromocell Therapeutics' direct competition is more important than ever and may enhance your ability to predict Chromocell Therapeutics' future price movements. Getting to know how Chromocell Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Chromocell Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TVRD | Tvardi Therapeutics | (0.11) | 6 per month | 0.00 | (0.09) | 5.59 | (5.80) | 17.33 | |
| TNFA | TNF Pharmaceuticals | 0.47 | 8 per month | 0.00 | (0.05) | 17.75 | (20.86) | 79.44 | |
| OMGA | Omega Therapeutics | 0.01 | 3 per month | 23.86 | 0.05 | 72.73 | (52.09) | 155.58 | |
| TSBX | Turnstone Biologics Corp | 0.19 | 8 per month | 3.05 | 0.04 | 6.06 | (6.06) | 21.24 | |
| CRVO | CervoMed | 0.07 | 7 per month | 0.00 | (0.10) | 6.31 | (7.29) | 19.42 | |
| APGN | Apexigen | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CSCI | COSCIENS Biopharma | (0.04) | 4 per month | 10.84 | 0.04 | 36.74 | (28.04) | 94.83 | |
| BIOR | Biora Therapeutics | 0.59 | 12 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OBSV | ObsEva SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Chromocell Therapeutics Additional Predictive Modules
Most predictive techniques to examine Chromocell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chromocell using various technical indicators. When you analyze Chromocell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Chromocell Therapeutics Predictive Indicators
The successful prediction of Chromocell Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Chromocell Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Chromocell Therapeutics based on analysis of Chromocell Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Chromocell Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chromocell Therapeutics's related companies.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Chromocell Stock
If you are still planning to invest in Chromocell Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chromocell Therapeutics' history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |